The Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) developed by our company have received the registration certificate from the National Medical Products Administration recently. In order to prevent some organizations and individuals from carrying out false publicity and sales by falsely using the name of “Zhuhai Livzon Diagnostics Inc.”, we hereby declare that:
1. The Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) developed by our company is only designated for in vitro qualitative detection of IgM / IgG antibody to coronavirus (2019-nCoV) in human serum, plasma and venous whole blood. It is only used as supplementary detection index for suspected case with negative result in nucleic acid detection of 2019-nCoV, or used in conjunction with nucleic acid detection for diagnosis of suspected case. It cannot be used as the basis for diagnosis and ruling out of COVID-19, and is not suitable for screening in general population. Medical institutions use only. Where the reagent developed by our company is used beyond the intended use, all resulting liabilities shall be borne by the party using it improperly and the sales party. Our company shall not take any liability and reserves the right to pursue legal liabilities.
2. Our company strictly follows relevant national requirements and emphasizes supervision and management of product promotion. Any company or individual without legal authorization from our company shall not sell the product, nor sell the product on the Internet and social platforms. Our company shall not take any liability for any legal risk incurred by improper publicity and sales by any company or individual, and reserves the right to pursue legal liabilities.
3. In case the publicity of any company or individual does not conform to above usage, or any company or individual fails to provide the authorization document issued by our company, please call Livzon hotline for public report: 400 830 4880.